1. Home
  2. IRON vs BCC Comparison

IRON vs BCC Comparison

Compare IRON & BCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$68.20

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

BCC

Boise Cascade L.L.C.

HOLD

Current Price

$67.93

Market Cap

2.9B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
BCC
Founded
2017
2004
Country
United States
United States
Employees
N/A
7680
Industry
Biotechnology: Pharmaceutical Preparations
RETAIL: Building Materials
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.9B
IPO Year
2020
2012

Fundamental Metrics

Financial Performance
Metric
IRON
BCC
Price
$68.20
$67.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
5
Target Price
$103.18
$99.20
AVG Volume (30 Days)
426.0K
427.6K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
1.11%
EPS Growth
N/A
N/A
EPS
N/A
0.50
Revenue
N/A
$4,995,290,000.00
Revenue This Year
N/A
$3.41
Revenue Next Year
$283.52
$4.76
P/E Ratio
N/A
$134.08
Revenue Growth
N/A
12.71
52 Week Low
$40.00
$65.00
52 Week High
$99.50
$95.00

Technical Indicators

Market Signals
Indicator
IRON
BCC
Relative Strength Index (RSI) 51.91 39.79
Support Level $58.13 $66.20
Resistance Level $71.53 $73.89
Average True Range (ATR) 3.23 2.58
MACD -0.17 -0.21
Stochastic Oscillator 46.09 26.06

Price Performance

Historical Comparison
IRON
BCC

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About BCC Boise Cascade L.L.C.

Boise Cascade Co is a producer of engineered wood products (EWP) and plywood. The firm operates in two reportable segments, namely Wood Products and Building Materials Distribution. The Wood Products segment manufactures laminated veneer lumber (LVL), I-joists, and laminated beams. In addition, it manufactures structural, appearance, and industrial-grade plywood panels, and ponderosa pine lumber. The Building Materials Distribution segment is engaged in the distribution of various building materials, including oriented strand board (OSB), plywood, and lumber; general line items such as siding, composite decking, doors and millwork, metal products, roofing, and insulation; and EWP, among others. The company generates a majority of its revenue from the Building Material Distribution segment.

Share on Social Networks: